Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes

Clinical Hemorheology and Microcirculation

Volumn 29, Issue 2, 2003, Pages 81-94

  Marton, Zs ^a   Horvath, B ^a   Alexy, T ^a   Kesmarky, G ^a   Gyevnar, Zs ^a   Czopf, L ^a   Habon, T ^a   Kovacs, L ^a   Papp, E ^a   Mezey, B ^a   Roth, E ^a   Juricskay, I ^a   Toth, K ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; COUMARIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CELL SEPARATION; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HEART MUSCLE ISCHEMIA; HEMATOCRIT; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT; PLASMA VISCOSITY; RISK FACTOR; THROMBOCYTE AGGREGATION;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; REFERENCE VALUES; TIME FACTORS;

EID: 0345304967     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. W.S. Aronow, Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease, Drugs Aging 15 (1999), 91-101.
2. K.A. Ault, C.P. Cannon, J. Mitchell, J. McCahan, R.P. Tracy, W.F. Novotny, J.D. Reimann and E. Braunwald, Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial, J. Am. Coll. Cardiol. 33 (1999), 634-639.
3. O.K. Baskurt, R. Levi, S. Caglayan, N. Dikmenoglu, O. Ucer, R. Guner and S. Yorukan, The role of hemorheologic factors in the coronary circulation, Clin. Hemorheol. 11 (1991), 121-127.
4. C. Carter, D. McGee, D. Reed, K. Yano and G. Stemmermann, Hematocrit and the risk of coronary heart disease: The Honolulu Heart Program, Am. Heart. J. 105 (1983), 674-679.
5. A. Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol. 17 (1957), 237-246.
6. M.J. Davies, A.C. Thomas, P.A. Knapman and J.R. Hangartner, Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death, Circulation 73 (1986), 418-427.
7. J. Dormandy, Cardiovascular diseases, in: Clinical Hemorheology, S. Chien, J. Dormandy, E. Ernst and A. Matrai, eds, Martinus Nijhoff Publishers, Dordrecht, 1987, pp. 165-194.
8. EUROASPIRE Study Group, EUROASPIRE A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results, Eur. Heart J. 18 (1997), 1569-1582.
9. EUROASPIRE I and II Group, Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries, Lancet 357 (2001), 995-1001.
10. D.J. Fitzgerald, L. Roy, F. Catella and G.A. Fitzgerald, Platelet activation in unstable coronary disease, N. Engl. J. Med. 315 (1986), 983-989.
11. D.J. Fitzgerald, Platelet activation in the pathogenesis of unstable angina: Importance in determining the response to plasminogen activators, Am. J. Cardiol. 68 (1991), 51B-57B.
12. T. Habon, K. Toth, B. Mezey, I. Juricskay and T. Javor, Hemorheological, ergometric and cardiac perfusion studies and their analysis in ischemic heart disease, Clin. Hemorheol. 11 (1991), 803 (abs.).
13. M.R. Hardeman, J. Vreeken, P.T. Goedhart and P.R. Oosting, Transient aggregation resistance of human blood platelets in fresh plasma. I. Methodology, Thromb. Res. 54 (1989), 719-731.
14. P.D. Hirsh, L.D. Hillis, W.B. Campbell, B.G. Firth and J.T. Willerson, Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease, N. Engl. J. Med. 304 (1981), 685-691.
15. S.M. Jafri, B.L. Walters and S. Borzak, Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy, J. Intensive Care Med. 10 (1995), 54-63.
16. R. Junker, J. Heinrich, H. Ulbrich, H. Schulte, R. Schönfeld, E. Köhler and G. Assmann, Relationship between plasma viscosity and the severity of coronary heart disease, Arterioscler. Thromb. Vasc. Biol. 18 (1998), 870-875.
17. W.B. Kannel, R.B. D'Agostino and A.J. Belanger, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study, Am. Heart J. 113 (1987), 1006-1010.
18. G. Kesmarky, K. Toth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin. Hemorheol. Microcirc. 18 (1998), 245-251.
19. G. Kesmarky, K. Toth, G. Vajda, L. Habon, R. Halmosi and E. Roth, Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty, Clin. Hemorheol. Microcirc. 24 (2001), 33-41.
20. H.J. Klose, E. Volger, H. Brechtelsbauer, L. Heinich and H. Schmid-Schonbein, Microrheology and light transmission of blood, Pflugers Arch. 333 (1972), 126-139.
21. A.J. Lee, P.I. Mowbray, G.D.O. Lowe, A. Rumley, F.G.R. Fowkes and P.L. Allan, Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study, Circulation 97 (1998), 1467-1473.
22. G.D.O. Lowe, M.M. Drummond, A.R. Lorimer, I. Hutton, C.D. Hutton, C.R.M. Prentice and J.C. Barbenel, Relation between extent of coronary heart disease and blood viscosity, Br. Med. J. 280 (1980), 673-674.
23. G.D.O. Lowe, F.G.R. Fowkes, J. Dawes, P.T. Donnan, S.E. Lennie and E. Housley, Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study, Circulation 87 (1993), 1915-1920.
24. J. Ma, C.H. Hennekens, P.M. Ridker and M.J. Stampfer, A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study, J. Am. Coll. Cardiol. 33 (1999), 1347-1352.
25. Zs. Marton, R. Halmosi, B. Horvath, T. Alexy, G. Kesmarky, J. Vekasi, I. Battyany, K. Hideg and K. Toth, Scavenger effect of experimental and clinically used cardiovascular drugs, J. Cardiovasc. Pharmacol. 38 (2001), 745-753.
26. R. Marchioli, F. Avanzini, F. Barzi, C. Chieffo, A. Di Castelnuovo, M.G. Franzosi, E. Geraci, A.P. Maggioni, R.M. Marfisi, N. Mininni, G.L. Nicolosi, M. Santini, C. Schweiger, L. Tavazzi, G. Tognoni and F. Valagussa, Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations. GISSI-Prevenzione mortality risk chart, Eur. Heart J. 22 (2001), 2085-2103.
27. F.J. Neumann, H. Tillmanns, P. Roebruck, R. Zimmermann, H.M. Maupt and W. Kubler, Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity, Br. Heart J. 62 (1989), 421-428.
28. F.J. Neumann, H.A. Katus, E. Hoberg, P. Roebruck, M. Braun, H.M. Haupt, H. Tillmanns and W. Kubler, Increased plasma viscosity and erythrocyte aggregation - indicators of an unfavourable clinical outcome in patients with unstable angina pectoris, Br. Heart J. 66 (1991), 425-430.
29. M. Penco, S. Romano, A. Dagianti, Jr., M.G. Tozzi-Ciancarelli and A. Dagianti, Modifications of whole blood filterability during acute myocardial infarction, Clin. Hemorheol. Microcirc. 22 (2000), 153-159.
30. C. Rainer, D.T. Kawanishi, P.A.N. Chandraratna, R.M. Bauersachs, C.L. Reid, S.H. Rahimtoola and H.J. Meiselman, Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease, Circulation 76 (1987), 15-20.
31. P.M. Sweetnam, H.F. Thomas, J.W.G. Yarnell, A.D. Beswick, I.A. Baker and P.C. Elwood, Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease: The Caerphilly and Speedwell Studies, Eur. Heart J. 17 (1996), 1814-1820.
32. T. Thieme, K.D. Wernecke, R. Meyer, E. Brandenstein, D. Habedank, A. Hinz, S.B. Felix, G. Baumann and F.X. Kleber, Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes, J. Allergy Clin. Immunol. 28 (1996), 1-6.
33. K. Toth, B. Mezey, I. Juricskay and T. Javor, Hemorheological changes during the hospital phase of acute myocardial infarction: sex differences?, Med. Sci Res. 17 (1989), 841-844.
34. K. Toth, T. Habon, I. Horvath, B. Mezey, I. Juricskay and Gy. Mozsik, Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise, Clin. Hemorheol. 14 (1994), 329-338.
35. K. Toth, L. Bogar, I. Juricskay, M. Keltai, S. Yusuf, L.J. Haywood and H.J. Meiselman, The effect of RheothRx injection on the hemorheological parameters in patients with acute myocardial infarction (CORE Trial substudy), Clin. Hemorheol. Microcirc. 17 (1997), 117-125.
36. J.W. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O-Brien, P.J. Whitehead and P.C. Elwood, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies, Circulation 83 (1991), 836-844.